Centrum Medyczne ENEL-MED (WAR:ENE) Current Deferred Revenue: zł0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:ENE Centrum Medyczne ENEL-MED SA WAR:ENE
75 GF Score
Price zł20.00
GF Value zł25.50
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED Current Deferred Revenue?

Centrum Medyczne ENEL-MED WAR:ENE -0.99% 75 Current Deferred Revenue is zł0.0 Mil as of Mar. 2026. GuruFocus rates WAR:ENE with a GF Score™ of 75/100 and a GF Value™ of zł25.50 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Centrum Medyczne ENEL-MED's current deferred revenue for the quarter that ended in Mar. 2026 was zł0.0 Mil.

Centrum Medyczne ENEL-MED Current Deferred Revenue Related Terms

Centrum Medyczne ENEL-MED Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Centrum Medyczne ENEL-MED's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centrum Medyczne ENEL-MED Current Deferred Revenue Chart

Centrum Medyczne ENEL-MED Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Centrum Medyczne ENEL-MED Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:ENE
75GF Score
Centrum Medyczne ENEL-MED SA WAR:ENE
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of zł0.0 Mil mean?
Centrum Medyczne ENEL-MED (WAR:ENE) has a Current Deferred Revenue of zł0.0 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Centrum Medyczne ENEL-MED and its competitors.
Is Centrum Medyczne ENEL-MED's Current Deferred Revenue too high?
Centrum Medyczne ENEL-MED's current Current Deferred Revenue is zł0.0 Mil. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's Current Deferred Revenue compare to HCA and THC?
Centrum Medyczne ENEL-MED's Current Deferred Revenue of zł0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Centrum Medyczne ENEL-MED and its competitors. Centrum Medyczne ENEL-MED's current Current Deferred Revenue is zł0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.50, compared to a current price of zł20.00 — trading 21.6% below its estimated fair value. The current Current Deferred Revenue is zł0.0 Mil. Centrum Medyczne ENEL-MED's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current Current Deferred Revenue is zł0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of zł20.00 is trading 21.6% below its estimated GF Value™ of zł25.50. GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.

Key valuation signals for WAR:ENE:

  • Current Deferred Revenue: zł0.0 Mil
  • GF Value™: zł25.50 vs. price of zł20.00 (21.6% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centrum Medyczne ENEL-MED Business Description

Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
75GF Score

Get the complete analysis for WAR:ENE

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł20.00
Price
zł25.50
GF Value